SOLICITATION NOTICE
A -- Amanitin EIA, 96 wells,
- Notice Date
- 12/6/2007
- Notice Type
- Solicitation Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- Reference-Number-FDA1037847
- Response Due
- 12/21/2007
- Archive Date
- 1/5/2008
- Point of Contact
- David Kordel, Contract Specialist, Phone 301-827-7166, Fax 301-827-7151, - Patricia Wright, Contract Specialist, Phone 301-827-7217, Fax 301-827-7101
- E-Mail Address
-
david.kordel@fda.hhs.gov, patricia.wright@fda.hhs.gov
- Description
- The Food and Drug Administration (FDA) intends to award a purchase order on a non-competitive sole source basis to ALPCO-American Laboratory Products Co. LTD, 26 Keewaydin Drive Unit G, Salem, NH 03079-4821. FDA will purchase eighty-four (84) Amanitin EIA, 96 wells, ?ROU? kits. The kits will be used to detect the characterization of food borne pathogens. The methods used in the detection program using known and proven methods that have been approved by the Center for Disease Control (CDC) for all labs in the USA to measure and detect microbial phenotypes. ALPCO-American Laboratory Products Company is the sole manufacturer of the Amanitin test kits. CDC has approved no other method for the detection program submitted by FDA under the select agent registered program and there are no potential substitutes. There are no other vendors that are known that can provide the necessary kits for this research project. As the only known standard kits capable of providing the capability necessary, the Amanitin test kits provides uniformity with the de facto international standard for research and rapid response. This notice of intent is NOT a request for competitive offers. However, all offers received within seven days after date of publication of this synopsis will be considered by the Government. A determination by the Government not to compete this requirement based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Sources intending to provide submittals must submit detailed information indicating their ability to meet the Government?s requirements. All inquiries must be received by 2 PM (1400) EST on 21 December 2007 to the attention of David Kordel, david.kordel@fda.hhs.gov. The FDA intends to make an award immediately after the response date of this notice. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures.
- Record
- SN01464923-W 20071208/071206223558 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |